People who took experimental peptides like BPC-157 describe side effects including migraines, eye pain and fatigue. The full report covers what users say went wrong.
Recap by typeshit. Post by KFF Health News on X.
One study cited by @fittrwithsquats put the risk of non-scarring hair loss about 40% higher with GLP-1 use, mostly telogen effluvium. Nail findings are less consistent.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
Research shown at the EADV Congress 2026 found 39% of users reported nails lifting versus 9% of non-users, plus more hair loss. It's self-reported and shows no causation.
3:15
CBS News reports two deaths tied to an unregulated weight-loss drug sold outside approved channels. The full investigation has the details.
Loading…